1. HIV/HCV Medication Guide
  2. Professional tools
  3. Pharmacology of antiretrovirals

Pharmacology of antiretrovirals

This guide provides information for healthcare professionals on each of the antiretrovirals.

It includes the following sections:

  • Dosage
  • Adverse effects
  • Pharmacokinetics
  • Pregnancy and breastfeeding
  • More specific features for each

Note that our pharmacists and documentalists are currently working to update and complete the pharmacological data sheets for antiretrovirals. Some data may be missing.

Select a drug

Bictegravir (BIC) + Emtricitabine (FTC) + Tenofovir alafenamide (TAF)
Biktarvy®
Dolutegravir (DTG) + Abacavir (ABC) + Lamivudine (3TC)
Triumeq®
Dolutegravir (DTG) + Lamivudine (3TC)
Dovato®
Dolutegravir (DTG) + Rilpivirine (RPV)
Juluca®
Doravirine (DOR)
Pifeltro®
Doravirine (DOR) + Lamivudine (3TC) + Tenofovir DF (TDF)
Delstrigo®
Elvitegravir (EVG) + Cobicistat (COBI) + Emtricitabine (FTC) + Tenofovir alafenamide (TAF)
Genvoya®
Raltegravir (RAL)
Isentress® and Isentress® HD
Rilpivirine (RPV) + Emtricitabine (FTC) + Tenofovir alafenamide (TAF)
Odefsey®

Authors

Rachel Therrien, Bpharm, Msc., pharmacist
UHRESS (Unité hospitalière de recherche, d’enseignement et de soins sur le sida) du CHUM (Centre hospitalier de l’Université de Montréal)

In collaboration with

Laurence Messier, Pharm D, M.Sc., pharmacist
Chronic Viral Illness Service, McGill University Health Center (MUHC)

Do you have comments? They are important to us.

You can send us your suggestions after identification and we will try to answer them as soon as possible.

SUBMIT A COMMENT